联环药业(600513.SH)子公司联环(安庆)拟向普林斯(安庆)购买部分房屋建(构)筑物及土地使用权

Core Viewpoint - Lianhuan Pharmaceutical (600513.SH) aims to enhance its asset stability and risk resistance through the acquisition of real estate and land use rights, indicating a strategic move for long-term sustainable development [1] Group 1: Transaction Details - Lianhuan Pharmaceutical's wholly-owned subsidiary, Lianhuan (Anqing), plans to purchase certain buildings and land use rights from Printers (Anqing) [1] - The transaction price is set at 74.5 million RMB (excluding tax), based on the asset evaluation results from Tianyuan Asset Appraisal Co., Ltd [1]